Land: Australien
Sprache: Englisch
Quelle: Department of Health (Therapeutic Goods Administration)
nicotine polacrilex, Quantity: 10 mg (Equivalent: nicotine, Qty 2 mg)
Johnson & Johnson Pacific Pty Ltd
Gum, chewing
Excipient Ingredients: glycerol; sodium carbonate; sorbitol; sodium bicarbonate; Flavour; calcium carbonate; butylated hydroxytoluene; isobutylene/isoprene copolymer; polyisobutylene; polyethylene; polyvinyl acetate; glycerol ester of gum rosin; glycerol ester of polymerised rosin; microcrystalline wax; mono- and di- glycerides
Buccal, Oral
400 piece pack size, 315 piece pack size, 30 chewing tablets (sample), 300 piece pack size, 10 chewing tablets, 60, 75 chewing t
Not scheduled. Not considered by committee
For the treatment of tobacco dependence by relieving nicotine craving and withdrawal symptoms thus facilitating smoking cessation in smokers motivated to quit. In smokers unable or not ready to stop smoking abruptly, the inhaler or gum may also be used as part of a smoking reduction strategy as a step towards stopping completely.
Visual Identification: Square beige pieces, 14.5mm x 14.5mm x approx 5.4mm; Container Type: Blister Pack; Container Life Time: 30 Months; Container Temperature: Store below 25 degrees Celsius
Registered
1991-08-13